Friday, January 8, 2010
What is a Pharmaceutical Litigation Attorney?
In spite of the rigorous approval process employed by the Food and Drug Administration (FDA), some drugs certified as safe can still result in serious side effects. These side effects can lead to irreversible damage and even death. When people suffer injury or illness, or even lose a loved one due to dangerous drugs, a pharmaceutical litigation attorney can help them receive compensation for their injuries.
How to Find a Pharmaceutical Litigation Attorney
If you are in need of a pharmaceutical litigation attorney, be sure to do some research before making a decision. While many attorneys handle this kind of case, it is important to find someone who is not only familiar with the pharmaceutical litigation process, but who is also familiar with the drug which has caused your injuries. For example, if you have suffered serious side effects due to using Accutane to treat acne, a lawyer who is familiar with existing lawsuits involving Accutane will be much better equipped to help you make a case.
Filing a Pharmaceutical Injury Lawsuit
If you feel you might be entitled to compensation due to harmful side effects from a drug, it is important to keep track of certain information that will be useful to your pharmaceutical injury attorney. Be sure to make note of:
- The type of drug you were taking
- The dosage and quantity you were prescribed
- The side effects you experienced
- Whether you experienced side effects while taking the drug or shortly thereafter
This information could be vital in not only making a case for yourself, but in collecting information about dangerous side effects that could help those seeking compensation later, or for organizations who keep records of dangerous drug reactions.
If you have suffered severe side effects while taking Accutane or any other prescription medication, please contact a pharmaceutical injury attorney in your area today for more information about your rights and possible compensation.
posted by
Erica
at
8:18 AM
0
comments
